Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Effectiveness and Safety of Add-on Milgamma® and Milgamma® Compositum Step-Therapy in Routine Practice of Management of Adult Patients With Acute Non-Specific Low Back Pain Receiving Modern NSAIDs

NCT03892707 is registered in ClinicalTrials.gov with Woerwag Pharma LLC as lead sponsor.

NCT NCT03892707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03892707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Effectiveness and Safety of Add-on Milgamma® and Milgamma® Compositum Step-Therapy in Routine Practice of Management of Adult Patients With Acute Non-Specific Low Back Pain Receiving Modern NSAIDs
Lead sponsor
Woerwag Pharma LLC
Phase
Observational
Overall status
Completed
Start date
December 15, 2018
Completion date
November 5, 2019
Enrollment
500 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

acute non-specific low back pain